1Yorkshire Cancer Research Laboratory of Drug Design, University Cancer Medicine Unit, University of Bradford, Bradford, West Yorkshire, BD7 1DP, UK. t.c.jenkins@brad.ac.uk
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study designs agents for recognizing DNA triplexes and tetraplexes, crucial for antigene therapies and telomerase inhibition. Chemical modifications enhance DNA drug binding affinity and specificity for targeted treatments.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: